抗逆转录病毒治疗的HIV-1患者脑脊液可携带耐药病毒
提示即使血浆病毒载量受控,仍需检测脑脊液HIV病毒载量和基因型以发现耐药。
要点
- 14%脑脊液病毒载量可检出的认知障碍患者血浆病毒载量控制良好。
- 血浆病毒载量<1.7 log10 copies/mL组脑脊液病毒载量更低、CD4更高。
- 两组患者脑脊液中均可观察到抗逆转录病毒耐药。
核心结论
- 部分接受抗逆转录病毒治疗且血浆病毒载量控制良好的HIV-1患者,脑脊液中仍可检出耐药病毒。
研究设计与样本
- 在法国22个中心和瑞士1个中心收集227例接受抗逆转录病毒治疗、因神经系统疾病就诊患者的血液和脑脊液样本,并对脑脊液进行HIV基因型耐药检测。
主要发现
- 227例脑脊液病毒载量>1.7 log10 copies/mL的患者中,195例血浆病毒载量可检出,中位数(IQR)为3.7(2.7-4.7)log10 copies/mL。
- 32例血浆病毒载量<1.7 log10 copies/mL,占14%。
- 血浆病毒载量<1.7 log10 copies/mL组脑脊液病毒载量中位数2.8 log10 copies/mL低于另一组的4.0 log10 copies/mL(P<0.001)。
- 血浆病毒载量<1.7 log10 copies/mL组CD4细胞计数中位数476 cells/mm3高于另一组的214 cells/mm3(P<0.001)。
- 两组患者脑脊液中均观察到抗逆转录病毒耐药。
关键数值与推荐
- 脑脊液病毒载量>1.7 log10 copies/mL为入组阈值。
- 血浆病毒载量<1.7 log10 copies/mL定义为血浆病毒载量不一致组。
- 基因型敏感性评分依据ANRS AC11基因型解读算法计算。
临床怎么用
- 对接受抗逆转录病毒治疗且出现认知障碍的HIV患者,即使血浆病毒载量控制良好,也应考虑检测脑脊液HIV病毒载量和基因型以发现耐药。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: HIV therapy reduces the CSF HIV RNA viral load (VL) and prevents disorders related to HIV encephalitis. However, these brain disorders may persist in some cases. A large population of antiretroviral-treated patients who had a VL > 1.7 log 10 copies/mL in CSF with detectable or undetectable VL in plasma associated with cognitive impairment was studied, in order to characterize discriminatory factors of these two patient populations. METHODS: Blood and CSF samples were collected at the time of neurological disorders for 227 patients in 22 centres in France and 1 centre in Switzerland. Genotypic HIV resistance tests were performed on CSF. The genotypic susceptibility score was calculated according to the last Agence Nationale de Recherche sur le Sida et les hépatites virales Action Coordonnée 11 (ANRS AC11) genotype interpretation algorithm. RESULTS: Among the 227 studied patients with VL > 1.7 log 10 copies/mL in CSF, 195 had VL detectable in plasma [median (IQR) HIV RNA was 3.7 (2.7-4.7) log 10 copies/mL] and 32 had discordant VL in plasma (VL < 1.7 log 10 copies/mL). The CSF VL was lower (median 2.8 versus 4.0 log 10 copies/mL; P < 0.001) and the CD4 cell count was higher (median 476 versus 214 cells/mm 3 ; P < 0.001) in the group of patients with VL < 1.7 log 10 copies/mL in plasma compared with patients with plasma VL > 1.7 log 10 copies/mL. Resistance to antiretrovirals was observed in CSF for the two groups of patients. CONCLUSIONS: Fourteen percent of this population of patients with cognitive impairment and detectable VL in CSF had well controlled VL in plasma. Thus, it is important to explore CSF HIV (VL and genotype) even if the HIV VL is controlled in plasma because HIV resistance may be observed.
引用
- Soulie C, Grudé M, Descamps D, et al. Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma. J Antimicrob Chemother. 2017. PMID: 28472307. doi:10.1093/jac/dkx128
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。